[1]
Karakiewicz, P.I. et al. 2018. Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Canadian Urological Association Journal. 12, 6 (Mar. 2018), 173–80. DOI:https://doi.org/10.5489/cuaj.5187.